This peer-reviewed article explores the role and effectiveness of multi-agent chemotherapy in the treatment of adolescent Alveolar Rhabdomyosarcoma (ARMS), one of the most aggressive and challenging childhood and young adult cancers. The review examines current treatment approaches, therapeutic outcomes, and the ongoing need for improved research and innovation to enhance survival and quality of life for patients affected by this rare disease.
The article was published in the Clinical Medicine and Health Research Journal (CMHRJ) in May 2026 and focuses on chemotherapy strategies used in adolescent ARMS treatment
